520 related articles for article (PubMed ID: 20430037)
1. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
[TBL] [Abstract][Full Text] [Related]
2. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.
Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R
J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164
[TBL] [Abstract][Full Text] [Related]
3. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.
Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD
J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166
[TBL] [Abstract][Full Text] [Related]
4. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
Reed JR; Huber WJ; Backes WL
Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells.
Young SC; Storm MV; Speed JS; Kelsen S; Tiller CV; Vera T; Drummond HA; Stec DE
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1546-53. PubMed ID: 19759334
[TBL] [Abstract][Full Text] [Related]
6. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway.
Pachori AS; Smith A; McDonald P; Zhang L; Dzau VJ; Melo LG
J Mol Cell Cardiol; 2007 Nov; 43(5):580-92. PubMed ID: 17920074
[TBL] [Abstract][Full Text] [Related]
7. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
Ali F; Hamdulay SS; Kinderlerer AR; Boyle JJ; Lidington EA; Yamaguchi T; Soares MP; Haskard DO; Randi AM; Mason JC
J Thromb Haemost; 2007 Dec; 5(12):2537-46. PubMed ID: 17927807
[TBL] [Abstract][Full Text] [Related]
8. Biliverdin reductase: a major physiologic cytoprotectant.
Baranano DE; Rao M; Ferris CD; Snyder SH
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16093-8. PubMed ID: 12456881
[TBL] [Abstract][Full Text] [Related]
9. Protective role of biliverdin against bile acid-induced oxidative stress in liver cells.
Gonzalez-Sanchez E; Perez MJ; Nytofte NS; Briz O; Monte MJ; Lozano E; Serrano MA; Marin JJG
Free Radic Biol Med; 2016 Aug; 97():466-477. PubMed ID: 27387768
[TBL] [Abstract][Full Text] [Related]
10. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.
Barone E; Di Domenico F; Mancuso C; Butterfield DA
Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978
[TBL] [Abstract][Full Text] [Related]
11. Biliverdin reductase deficiency triggers an endothelial-to-mesenchymal transition in human endothelial cells.
Klóska D; Kopacz A; Piechota-Polańczyk A; Neumayer C; Huk I; Dulak J; Józkowicz A; Grochot-Przęczek A
Arch Biochem Biophys; 2019 Dec; 678():108182. PubMed ID: 31704097
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications of bilirubin and biliverdin in transplantation.
Ollinger R; Wang H; Yamashita K; Wegiel B; Thomas M; Margreiter R; Bach FH
Antioxid Redox Signal; 2007 Dec; 9(12):2175-85. PubMed ID: 17919067
[TBL] [Abstract][Full Text] [Related]
13. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles.
Sedlak TW; Saleh M; Higginson DS; Paul BD; Juluri KR; Snyder SH
Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5171-6. PubMed ID: 19286972
[TBL] [Abstract][Full Text] [Related]
14. The heme oxygenase/biliverdin reductase system in skin cancers.
Arena V; Pennacchia I; Guerriero G; Mancuso C
J Biol Regul Homeost Agents; 2015; 29(1):259-64. PubMed ID: 25864768
[TBL] [Abstract][Full Text] [Related]
15. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells.
Foresti R; Bains SK; Pitchumony TS; de Castro Brás LE; Drago F; Dubois-Randé JL; Bucolo C; Motterlini R
Pharmacol Res; 2013 Oct; 76():132-48. PubMed ID: 23942037
[TBL] [Abstract][Full Text] [Related]
16. Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes.
Rochette L; Zeller M; Cottin Y; Vergely C
Trends Endocrinol Metab; 2018 Feb; 29(2):74-85. PubMed ID: 29249571
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of the antioxidant enzymes biliverdin reductase and heme oxygenase-2 in human and pig gastric fundus.
Colpaert EE; Timmermans JP; Lefebvre RA
Free Radic Biol Med; 2002 Apr; 32(7):630-7. PubMed ID: 11909697
[TBL] [Abstract][Full Text] [Related]
18. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells.
Kim HP; Wang X; Galbiati F; Ryter SW; Choi AM
FASEB J; 2004 Jul; 18(10):1080-9. PubMed ID: 15226268
[TBL] [Abstract][Full Text] [Related]
19. The heme oxygenase/biliverdin reductase pathway in drug research and development.
Mancuso C; Barone E
Curr Drug Metab; 2009 Jul; 10(6):579-94. PubMed ID: 19702533
[TBL] [Abstract][Full Text] [Related]
20. Unconjugated bilirubin mediates heme oxygenase-1-induced vascular benefits in diabetic mice.
Liu J; Wang L; Tian XY; Liu L; Wong WT; Zhang Y; Han QB; Ho HM; Wang N; Wong SL; Chen ZY; Yu J; Ng CF; Yao X; Huang Y
Diabetes; 2015 May; 64(5):1564-75. PubMed ID: 25475440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
